267 related articles for article (PubMed ID: 32640984)
1. Molecular docking and machine learning analysis of Abemaciclib in colon cancer.
Liñares-Blanco J; Munteanu CR; Pazos A; Fernandez-Lozano C
BMC Mol Cell Biol; 2020 Jul; 21(1):52. PubMed ID: 32640984
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
3. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
5. Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma.
Gu L; Liu Y; Jiang C; Sun L; Zhou H
Pharmacol Res; 2020 Oct; 160():105087. PubMed ID: 32683036
[TBL] [Abstract][Full Text] [Related]
6. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
7. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
8. Abemaciclib for the treatment of breast cancer.
Kotake T; Toi M
Expert Opin Pharmacother; 2018 Apr; 19(5):517-524. PubMed ID: 29522364
[TBL] [Abstract][Full Text] [Related]
9. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM.
Xu G; Zhang M; Zhu H; Xu J
Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790
[TBL] [Abstract][Full Text] [Related]
10. Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature.
Knudsen ES; Hutcheson J; Vail P; Witkiewicz AK
Oncotarget; 2017 Jul; 8(27):43678-43691. PubMed ID: 28620137
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate genes encoding tumor-specific neoantigens in early- and late-stage colon adenocarcinoma.
Wang C; Xue W; Zhang H; Fu Y
Aging (Albany NY); 2021 Jan; 13(3):4024-4044. PubMed ID: 33428592
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Forkhead Box (FOX) Genes Association with Survival Prognosis, Anti-tumor Immunity, and Key Targeting Drugs in Colon Adenocarcinoma.
Xie Q; Wang J; Peng X
Arch Iran Med; 2023 Sep; 26(9):510-528. PubMed ID: 38310407
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
14. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
[TBL] [Abstract][Full Text] [Related]
15. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
16. An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers.
Eskandari E; Mahjoubi F; Motalebzadeh J
Gene; 2018 Dec; 679():150-159. PubMed ID: 30193961
[TBL] [Abstract][Full Text] [Related]
17. Contributions of Gene Modules Regulated by Essential Noncoding RNA in Colon Adenocarcinoma Progression.
Li C; Yu X; Lu J; Zheng L; Xu D; Xu Z; Wang L; Cui Y; Li Y; Wang H; Xu J; Li K
Biomed Res Int; 2020; 2020():8595473. PubMed ID: 32280704
[TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Dong S; Ding Z; Zhang H; Chen Q
Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719
[No Abstract] [Full Text] [Related]
19. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
Liang L; Liu L; Mai S; Chen Y
Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]